Fundraising Fox

Chong Xu

Investor

Partner at F-Prime Capital Partners

Cambridge, Massachusetts

Writes $100K – $10M checks · typically $5M

About

Chong Xu is a Partner at F-Prime who focuses on the biopharmaceutical and medical technology sectors, and collaborates with the Eight Roads Ventures Asia team on portfolio companies and investments in China. Before joining F-Prime in 2015, he worked as a management consultant at McKinsey and Company, as a healthcare equity analyst at Massif Partners and Affirmed Healthcare, and as a developmental neurobiology researcher at Temasek Life Sciences Laboratory in Singapore. He holds a PhD in Cell Biology and an MBA from the University of Virginia, and a B.S. in biology from Zhejiang University.

LinkedIn ↗

Invests in

BiotechMedical Devices

Experience

  1. F-Prime CapitalPartnercurrent2015 — presentGreater Boston Area
  2. University of Virginia Darden School of BusinessAlumni Boardcurrent2025 — present
  3. Focus BioMember Board of Directorscurrent2025 — present
  4. OnCusp TherapeuticsDirector Board of Directorscurrent2024 — present
  5. K36 Therapeutics, Inc.Director Board Of Directorscurrent2021 — presentBoston, Massachusetts, United States
  6. SironaxMember Board of Directorscurrent2019 — present
  7. Citrine Medicine / RareStone GroupDirector Board Of Directorscurrent2019 — present
  8. Geneception (Shanghai) Bio-technology Co.,Ltd. / Skyline TherapeuticsCo-Founder, Investor, Board Directorcurrent2019 — present
  9. LenoMedBoard Observercurrent2020 — present
  10. Yisheng GroupBoard Observer2015 — 2021
  11. AdageneDirector Board Of Directors2020 — 2021
  12. Eyebright Medical TechnologyBoard Observer2015 — 2020
  13. Semma TherapeuticsBoard Observer2017 — 2019
  14. Innovent Biologics（信达生物制药）Board Observer2015 — 2018
  15. McKinsey & CompanyAssociate2014 — 2015Greater Boston Area
  16. Darden School of BusinessMBA Class Of 20142012 — 2014Charlottesville, Virginia
  17. Massif PartnersDirector2011 — 2012Greenwich, CT
  18. Affirmed Capital LLCHealthcare Equity Analyst2009 — 2011
  19. Cell Biology, University of VirginiaGraduate Research2002 — 2009
  20. A*STAR/Temasek Life Sciences Laboratory (Former Institute of Molecular Agrobiology)Assistant Research Officer2001 — 2002

Education

  1. University of Virginia Darden School of BusinessMaster of Business Administration (MBA), Business Administration and Management
  2. University of VirginiaPh.D., Cell Biology
  3. National University of SingaporeVisiting Student, Institute of Molecular Agrobiology
  4. Zhejiang UniversityB.S., Biological Sciences&Technology

Skills & more

Healthcare7Life Sciences9Financial Analysis22Due Diligence5Financial Modeling21Market Research7Biotechnology16Molecular Biology35Research20Cell Biology15Biochemistry20Pharmaceuticals1
+4 moreOncologyEquity Researchinvestment analysisProblem Solving

Languages Chinese · English

From Chong's professional profile.

Same school

Also attended University of Virginia Darden School of Business98

Cathy FriedmanInvestor at GV (Google Ventures)Daniel LynchInvestor at GV (Google Ventures)Rajan MehraPartner at March Capital PartnersRob LudwigChief Operating Officer at Hoxton VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcKwame UlmerVenture Partner at Wavemaker Three-Sixty Health

+ 92 more

Also attended University of Virginia316

Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures

+ 310 more

Also attended National University of Singapore226

Justin HallPartner at Golden Gate VenturesMahati SridharPartner, Rise of the Rest at RevolutionCeline XiaoInvestor at DN CapitalSofia DahouneInvestor at DaphniYi Min LohInvestment Associate at Burda Principal InvestmentsSean LooInvestment Analyst at Burda Principal Investments

+ 220 more

Also attended Zhejiang University22

Albert WangSenior Director at Qualcomm VenturesEnrique OtiInvestor at Green FlagHong TangVenture Partner at Foothill VenturesTony GuGeneral Partner at NGC VenturesShu CaoManaging Director at Heuristic Capital PartnersHarry WangFounder and CEO at Linear Capital

+ 16 more

Shared employers

Also worked at University of Virginia Darden School of Business4

TR HarringtonPartner & Director of Growth at Orbit StartupsPascal G BouvierSenior Practitioner Advisor at SC VenturesSusan SobbottPartner at Lead Edge CapitalKellie BarrancoVice President at Freeman Spogli

Also worked at OnCusp Therapeutics1

Jiacong GuoVice President at BioTrack Capital

Also worked at Adagene1

Mickael Chane-DuPartner at Olive Tree Capital

Also worked at Innovent Biologics（信达生物制药）1

Wei LiGeneral Partner at 6 Dimensions Capital

Investments

Board seats

AdageneInnoventOnCusp TxRemunixSemma TxShinobi TxSironax

Investor

AlphaGen TxK36 TxPediatrixRareStone GroupSkyline Tx

Per the firm's website.

Colleagues at F-Prime Capital Partners

Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners

Network5

Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Alexander Pasteur
Partner at F-Prime Capital Partners
Bala Varadhan
Principal at F-Prime Capital Partners
Betsy Mulé
Principal at F-Prime Capital Partners

Investors connected to Chong in public investor directories — a warm-intro map.